Drug Companies Step Forward with Voluntary Price Caps on Inhalers

Jun 2, 2024 · Drug companies Boehringer Ingelheim, AstraZeneca and GSK are capping out-of-pocket costs for their asthma inhalers at $35 per month for eligible patients. The price caps for …

CouponFollow Extension

$35
OFF

Drug Companies Step Forward With Voluntary Price Caps On Inhalers

1 week from now

Jun 2, 2024 · Drug companies Boehringer Ingelheim, AstraZeneca and GSK are capping out-of-pocket costs for their asthma inhalers at $35 per month for eligible patients. The price caps for …

allergyasthmanetwork.org

$35
OFF

These Inhalers No Longer Cost More Than $35 Per Month

1 week from now

Mar 26, 2024 · The price caps come after lawmakers criticized the companies, along with Teva Pharmaceuticals, for having high prices. (Teva Pharmaceuticals has not announced plans for …

verywellhealth.com

$35
OFF

Some Drugmakers To Cap Cost Of Asthma Inhalers At $35 A Month

1 week from now

May 31, 2024 · Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer …

nbcnews.com

$35
OFF

Inhaler Manufacturer Caps Prices At $35 After Baldwin Launches ...

1 week from now

Mar 7, 2024 · WASHINGTON, D.C. – Boehringer Ingelheim, one of the biggest manufacturers of inhalers, today announced they will be capping the out-of-pocket cost for all their inhaler …

senate.gov

$35
OFF

Biden Administration Extends Efforts For $35 Monthly Asthma …

1 week from now

Apr 4, 2024 · Drug companies step forward with voluntary price caps on inhalers. Allergy & Asthma Network. ... Langowska V. Allergy & asthma network says $35 inhaler price cap will …

ajmc.com

$35
OFF

GSK Joins AstraZeneca, Boehringer In Capping US Out-of-pocket …

1 week from now

Mar 21, 2024 · Each drugmaker is capping out-of-pocket costs at $35 per month for their respective inhaler products. GSK's new price cap will take effect no later than January 1, …

fiercepharma.com

$35
OFF

Largest Inhaler Makers To Cap U.S. Prices At $35 A Month - NY1

1 week from now

Mar 21, 2024 · Three of the world’s four largest producers of inhalers have agreed to cap the price of their inhaler products and similar medicines at $35 a month for U.S. buyers following …

ny1.com

$35
OFF

Major Pharmaceutical Companies Put $35 Monthly Price Cap On

1 week from now

Mar 29, 2024 · Three of the largest producers of asthma inhalers have agreed to cap the price of their inhaler products at $35. This comes after several Democratic lawmakers asked …

healio.com

$35
OFF

GSK Announces Cap Of $35 Per Month On U.S. Patient Out-of …

1 week from now

Announcement builds on GSK’s decades-long commitment to making products accessible to those who need them; GSK today announced it will cap out-of-pocket costs for eligible patients …

gsk.com

$35
OFF

Companies Announce Price Cap For Inhalers; Asthma Patients ...

1 week from now

Apr 3, 2024 · He says the recent announcement of some major pharmaceutical companies capping the price of asthma inhalers and breathing medications to $35 by the end of the year …

tmj4.com

$35
OFF

Drugmaker Will Cap Inhaler Costs At $35 Per Month Amid Scrutiny

1 week from now

Mar 7, 2024 · Drugmaker Boehringer Ingelheim plans to cap the out-of-pocket costs for all its inhalers at $35 per month after coming under fire from Democratic lawmakers over pricing. …

thehill.com

$35
OFF

Biden Celebrates Drugmakers Capping Inhaler Costs At $35 Per …

1 week from now

Apr 3, 2024 · President Joe Biden and Sen. Bernie Sanders (I-Vt.) touted their efforts to lower drug prices on Wednesday following an announcement that several drugmakers will cap …

yahoo.com

$35
OFF

Major Drugmakers Cap Price Of Asthma Inhalers - WSBT

1 week from now

Jun 12, 2024 · The 4th major drug maker of asthma inhalers that have not currently announced a price cap is Teva Pharmaceuticals. Some monthly prescriptions are capped at $35 right now. …

wsbt.com

$35
OFF

Impact And Implications Of The $35 Monthly Price Cap On Asthma …

1 week from now

Jun 26, 2024 · In the US, a recent initiative by major pharmaceutical companies to cap the cost of asthma inhalers at $35 per month marks a significant development in healthcare affordability …

yahoo.com

FAQs about Drug Companies Step Forward with Voluntary Price Caps on Inhalers Coupon?

Are pharmaceutical companies capping out-of-pocket inhalers at $35?

Amidst untenable drug prices, there's finally some good news: Several pharmaceutical companies are capping the out-of-pocket price of select inhalers at $35. GlaxoSmithKline (GSK) is the latest company to announce a price cap this month, following the lead of AstraZeneca and Boehringer Ingelheim, who revealed their inhaler price ceilings in March. ...

Are pharmaceutical companies capping the price of inhalers?

Three major pharmaceutical companies have announced price caps for their inhalers. The inhalers treat patients with asthma and COPD. Changes were made in response to pressure from lawmakers. Amidst untenable drug prices, there's finally some good news: Several pharmaceutical companies are capping the out-of-pocket price of select inhalers at $35. ...

Which inhaler manufacturers have committed to a $35 price cap?

With the move, three leading inhaler manufacturers have committed to the $35 out-of-pocket monthly price cap. A fourth drugmaker, Teva, was also included in the HELP committee’s January investigation into the “outrageous” costs for asthma and COPD products on the U.S. market. ...

Is the $35 monthly price cap on asthma inhalers a win?

Additionally, by proactively addressing cost concerns, these companies may avoid more stringent regulatory measures in the future, thereby maintaining greater control over their pricing strategies and market operations. Overall, the $35 monthly price cap on asthma inhalers represents a multifaceted victory. ...

Should asthma inhalers be capped at $35 per month?

In the US, a recent initiative by major pharmaceutical companies to cap the cost of asthma inhalers at $35 per month marks a significant development in healthcare affordability and accessibility. ...

Will GlaxoSmithKline cap the cost of inhalers?

Following years of public outcry about the high cost of inhalers, the two drugmakers — along with a third, GlaxoSmithKline — have committed to capping the out-of-pocket cost at $35 a month. GSK’s cap is expected to take effect by Jan. 1. ...